Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Medeiros-Ribeiro

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Rheumatology (Oxford, England)|October 19, 2021
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2Samuel K Shinjo, Fernando H C de Souza, Isabela B P Borges, et al.
Revista Brasileira De Reumatologia|June 9, 2016
Guidelines for the management and treatment of periodic fever syndromes familial Mediterranean feverMaria Teresa R A Terreri, Wanderley Marques Bernardo, Claudio Arnaldo Len, et al.
Revista Brasileira De Reumatologia|June 9, 2016
Guidelines for the management and treatment of periodic fever syndromes: periodic fever, aphthous stomatitis, pharyngitis and adenitis syndromeMaria Teresa R A Terreri, Wanderley Marques Bernardo, Claudio Arnaldo Len, et al.
European Journal of Dermatology : EJD|May 8, 2023
Epidemiological profile of rosacea in dermatology outpatient clinics in Brazil: an observational report from the Brazilian study group on rosaceaMaria Victoria Suarez, Fábio Francesconi, Heitor Gonçalves, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 10, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patientsBruno Gualano, Carla G S Saad, Sofia M Sieczkowska, et al.
Advances in Rheumatology (London, England)|July 26, 2023
Extra-articular manifestations of rheumatoid arthritis remain a major challenge: data from a large, multi-centric cohortKarina Rossi Bonfiglioli, Ana Cristina de Medeiros Ribeiro, Ana Paula Carnieletto, et al.
Rheumatology (Oxford, England)|May 31, 2022
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccineNadia E Aikawa, Leonard V K Kupa, Clovis A Silva, et al.
Clinical Rheumatology|March 20, 2022
Inactivated SARS-CoV-2 vaccine in primary Sjögren's syndrome: humoral response, safety, and effects on disease activitySandra Gofinet Pasoto, Ari Stiel Radu Halpern, Lissiane Karine Noronha Guedes, et al.
The Lancet. Rheumatology|December 13, 2021
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective studyNadia E Aikawa, Leonard V K Kupa, Sandra G Pasoto, et al.
Nature Medicine|July 31, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trialAna C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Rheumatology (Oxford, England)|October 19, 2021
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2Samuel K Shinjo, Fernando H C de Souza, Isabela B P Borges, et al.
Revista Brasileira De Reumatologia|June 9, 2016
Guidelines for the management and treatment of periodic fever syndromes familial Mediterranean feverMaria Teresa R A Terreri, Wanderley Marques Bernardo, Claudio Arnaldo Len, et al.
Revista Brasileira De Reumatologia|June 9, 2016
Guidelines for the management and treatment of periodic fever syndromes: periodic fever, aphthous stomatitis, pharyngitis and adenitis syndromeMaria Teresa R A Terreri, Wanderley Marques Bernardo, Claudio Arnaldo Len, et al.
European Journal of Dermatology : EJD|May 8, 2023
Epidemiological profile of rosacea in dermatology outpatient clinics in Brazil: an observational report from the Brazilian study group on rosaceaMaria Victoria Suarez, Fábio Francesconi, Heitor Gonçalves, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 10, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patientsBruno Gualano, Carla G S Saad, Sofia M Sieczkowska, et al.
Advances in Rheumatology (London, England)|July 26, 2023
Extra-articular manifestations of rheumatoid arthritis remain a major challenge: data from a large, multi-centric cohortKarina Rossi Bonfiglioli, Ana Cristina de Medeiros Ribeiro, Ana Paula Carnieletto, et al.
Rheumatology (Oxford, England)|May 31, 2022
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccineNadia E Aikawa, Leonard V K Kupa, Clovis A Silva, et al.
Clinical Rheumatology|March 20, 2022
Inactivated SARS-CoV-2 vaccine in primary Sjögren's syndrome: humoral response, safety, and effects on disease activitySandra Gofinet Pasoto, Ari Stiel Radu Halpern, Lissiane Karine Noronha Guedes, et al.
The Lancet. Rheumatology|December 13, 2021
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective studyNadia E Aikawa, Leonard V K Kupa, Sandra G Pasoto, et al.
Nature Medicine|July 31, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trialAna C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, et al.
Pageof 13